Lamotrigine drug interactions in a TDM material

Therapeutic Drug Monitoring

Volumn 21, Issue 2, 1999, Pages 171-174

  Böttiger, Ylva ^a   Svensson, Jan Olov ^a   Ståhle, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Drug interactions; Lamotrigine; Plasma concentration

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MONITORING; EPILEPSY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CARBAMAZEPINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOBARBITAL; PHENYTOIN; TRIAZINES; VALPROIC ACID;

EID: 0342565851     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199904000-00006     Document Type: Article

References (13)

1. Burstein AH. Lamotrigine. Pharmacotherapy 1995;15:129-43.
2. Rambeck B, Wolf P. Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet 1993;25:433-43.
3. Enksson AS, Hoppu K, Nergardh A, Boreus L. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. Epilepsia 1996;37:769-73.
4. Anderson GD, Yau MK, Gidal BE, et al. Bidirectional interaction of valproate and lamotrigine in healthy subjects. Clin Pharmacol Ther 1996;60:145-56.
5. Rambeck B, Specht U, Wolf P. Pharmacokinetic interactions of the new antiepileptic drugs. Clin Pharmacokinet 1996;31:309-24.
6. Jerling M, Bertilsson L, Sjöqvist F. The use of therapeutic drug monitoring data to document kinetic drug interactions: the example with amitriptyline and nortriptyline. Ther Drug Monit 1994;16:1-12.
7. Vauzelle-Kervroedan F, Rey E, Cieuta C, et al. Influence of concurrent antiepileptic medication on the pharmacokinetics of lamotrigine as add-on therapy in epileptic children. Br J Clin Pharmacol 1996;41:325-30.
8. Eadie MJ. Plasma antiepileptic drug monitoring in a neurological practice: A 25-year experience. Ther Drug Monit 1994;16:458-68.
9. Swedish catalogue of approved medical products 1997. Stockholm: LINFO, Läkemedelsinformation, 1997.
10. Kilpatrick ES, Forrest G, Brodie MJ. Concentration - effect and concentration - toxicity relations with lamotrigine: a prospective study. Epilepsia 1996;37:534-8.
11. Bartoli A, Guerrini R, Belmonte A, Alessandri MG, Gatti G, Perucca E. The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response. Ther Drug Monit 1997;19:252-60.
12. Mattson RH. Antiepileptic drug monitoring: a reappraisal. Epilepsia 1995;36(suppl 5):22-9.
13. Gidal BE, Welty TE. The concentration-effect relationship with lamotrigine (LTG) [letter] Epilepsia 1997;38:260